Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 392

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 392
---
 |     |                 – |   |     |               (70 | ) |     |         (70 | ) |
| Gain recognised in finance income within the consolidated statement of comprehensive income |     |                 – |   |     |              (936 | ) |     |        (936 | ) |
| Interest accruing in period                                                                 |     |                23 |   |     |                 6 |   |     |          29 |   |
| At 31 December 2021                                                                         |     |               620 |   |     |               699 |   |     |       1,319 |   |

| F-55 |

| 15 | Trade and other payables |

| Schedule of trade and other payables                           |     |            |     |            |     |            |
| Current                                                        |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Trade payables                                                 |     |        314 |     |        339 |     |        485 |
| Other payables                                                 |     |          7 |     |         17 |     |          5 |
| Accruals                                                       |     |        857 |     |        817 |     |        546 |
| Total financial liabilities, excluding loans and borrowings,   
 classified as financial liabilities measured at amortised cost |     |      1,178 |     |      1,173 |     |      1,036 |
| Tax and social security                                        |     |         62 |     |         77 |     |         56 |
| Deferred revenue                                               |     |          – |     |        197 |     |          – |
| Total trade and other payables                                 |     |      1,240 |     |      1,447 |     |      1,092 |

Book values approximate
to fair value at 31 December 2023, 2022 and 2021.

All current trade and
other payables are payable within 3 months of the period end date shown above.

| 16 | Borrowings |

| Schedule of borrowings |     |            |     |            |     |            |
|                        |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Current                |     |            |     |            |     |            |
|